LEADER 00832nam0-2200301---450-
001 990008320170403321
005 20060504165621.0
010   $a0-444-01323-7
035   $a000832017
035   $aFED01000832017
035   $a(Aleph)000832017FED01
035   $a000832017
100   $a20060504d1989----km-y0itay50------ba
101 0 $aeng
102   $aUS
105   $aa-------001yy
200 1 $aPharmacotherapy$ea pathophysiologic approach$feditors Joseph T. DiPiro ... [et al.]
210   $aNew York [etc.]$cElsevier$d1989
215   $axx, 1730 p.$d29 cm
676   $a615.58
702  1$aDiPiro,$bJoseph T.
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990008320170403321
952   $a80 XIV C 23 CFT (21)$bCFT 374$fFFABC
959   $aFFABC
996   $aPharmacotherapy$9744642
997   $aUNINA

LEADER 01234nam--2200397---450-
001 990006020920203316
005 20150401110639.0
035   $a000602092
035   $aUSA01000602092
035   $a(ALEPH)000602092USA01
035   $a000602092
100   $a20150330d1934----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $a||||||||001yy
200 1 $aElementi di scienza e legislazione finanziaria$fSilvio Cardellicchio
205   $a3. ed. rifatta in conformitą dei programmi governativi 15 maggio 1933
210   $aCatania$cStudio editoriale moderno$d1934
215   $a264 p.$d22 cm
410  0$12001
454  1$12001
461  1$1001-------$12001
606 0 $aScienza delle finanze$2BNCF
676   $a336
700  1$aCARDELLICCHIO,$bSilvio$0405894
801  0$aIT$bsalbc$gISBD
912   $a990006020920203316
951   $aXV.2.C. 403$b6280 F.C.$cXV.2.C.$d368721
959   $aBK
969   $aCUOMO
979   $aGIGLIO$b90$c20150330$lUSA01$h1057
979   $aGIGLIO$b90$c20150330$lUSA01$h1106
979   $aGIGLIO$b90$c20150330$lUSA01$h1111
979   $aFIORELLA$b90$c20150401$lUSA01$h1106
996   $aElementi di scienza e legislazione finanziaria$91077528
997   $aUNISA